Filter...

OrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and Processes

Select a category...

CoccidioidinCoccidioidesCoccidioidomycosisTuberculin TestTuberculinAntigens, FungalSkin TestsHistoplasminCell Migration InhibitionComplement Fixation TestsImmunoelectrophoresis, Two-DimensionalHypersensitivity, DelayedAntibodies, FungalImmunodiffusionBCG VaccineTuberculosisLatent Tuberculosis

HistoplasminSkinHistoplasmin and coccidioidinPurified protein deMumpsAntigensInfection

Histoplasmin3

• Title : Histoplasmin, coccidioidin, and tuberculin sensitivity among school children in two Texas counties Personal Author(s) : Furcolow, Michael L.;Federspiel, Charles F.;Larsh, Howard W. (cdc.gov)
• However, only four are available as standardized antigens for use by a Mantoux-type procedure (0.1 ml of antigen administered intracutaneously): tuberculin, coccidioidin, histoplasmin, and mumps. (cdc.gov)
• sensitivity to histoplasmin and coccidioidin is restricted to endemic regions of infections. (cdc.gov)

Skin2

• These guidelines include the recommendation that all persons who are known to be infected with HIV, or are at increased risk of HIV infection, receive a tuberculin skin test (Mantoux test with tuberculin units 5 {TU} of purified protein derivative {PPD}-tuberculin). (cdc.gov)
• Thus, the guidelines presented below are intended for the evaluation and management of persons who may have tuberculous infection and HIV-induced anergy to delayed-type hypersen- sitivity (DTH) skin test antigens, including PPD-tuberculin. (cdc.gov)

Histoplasmin and coccidioidin1

• sensitivity to histoplasmin and coccidioidin is restricted to endemic regions of infections. (cdc.gov)

Purified protein de1

• These guidelines include the recommendation that all persons who are known to be infected with HIV, or are at increased risk of HIV infection, receive a tuberculin skin test (Mantoux test with tuberculin units 5 {TU} of purified protein derivative {PPD}-tuberculin). (cdc.gov)

Mumps2

• However, only four are available as standardized antigens for use by a Mantoux-type procedure (0.1 ml of antigen administered intracutaneously): tuberculin, coccidioidin, histoplasmin, and mumps. (cdc.gov)
• Previously available DTH Ags that were withdrawn from clinical use include the Cell-mediated immunity (CMI) multitest, coccidioidin, mumps, and histoplasmin. (medscape.com)

Antigens1

• Thus, the guidelines presented below are intended for the evaluation and management of persons who may have tuberculous infection and HIV-induced anergy to delayed-type hypersen- sitivity (DTH) skin test antigens, including PPD-tuberculin. (cdc.gov)

Infection1

• The Division of Tuberculosis Elimination (DTBE) in CDC's Center for Prevention Services has considered requests for information regarding screening for anergy among persons infected with HIV who are at increased risk of tuberculous infection but do not react to a tuberculin skin test. (cdc.gov)